AbbVie Inc. (ABBV) Debt / Equity
- 2025-12-31: Debt/Equity Ratio -20.49.
- 2024-12-31: Debt/Equity Ratio 20.1.
- 2023-12-31: Debt/Equity Ratio 5.72.
- 2022-12-31: Debt/Equity Ratio 3.66.
Complete source-backed debt/equity ratio history.
- Available history
- 2019-12-31 to 2025-12-31
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | -20.49 |
| 2024-12-31 | 20.1 |
| 2023-12-31 | 5.72 |
| 2022-12-31 | 3.66 |
| 2021-12-31 | 4.93 |
| 2020-12-31 | 6.5 |
| 2019-12-31 | -8.23 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | -20.49 |
| 2024-12-31 | 20.1 |
| 2023-12-31 | 5.72 |
| 2022-12-31 | 3.66 |
| 2021-12-31 | 4.93 |
| 2020-12-31 | 6.5 |
| 2019-12-31 | -8.23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |